Clinical Trials in Almaty, Kazakhstan
24 recruiting
Showing 1–17 of 17 trials
Recruiting
Phase 3
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Metabolic Dysfunction-Associated Steatohepatitis
Boehringer Ingelheim1,590 enrolled447 locationsNCT06632457
Recruiting
Phase 3
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Metabolic dysfunction-associated steatohepatitis (MASH)Liver Fibrosis
Boehringer Ingelheim1,800 enrolled526 locationsNCT06632444
Recruiting
Phase 2
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Inflammatory Bowel DiseasesCrohn's Disease
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)385 enrolled226 locationsNCT06226883
Recruiting
Not Applicable
Full-Thickness Macular Hole Surgery: A Comparison of Ten Techniques
Macular Holes
Kazakh Eye Research Institute120 enrolled1 locationNCT07606404
Recruiting
INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use
Systemic Lupus Erythematosus (SLE)
AstraZeneca200 enrolled6 locationsNCT06314282
Recruiting
Not Applicable
Morphometric Markers of the Effectiveness of Micropulse Cyclophotocoagulation
Glaucoma
Kazakh Eye Research Institute20 enrolled1 locationNCT07592923
Recruiting
Not Applicable
Tear Interleukin Biomarkers After Glaucoma Treatment
Glaucoma
Kazakh Eye Research Institute24 enrolled1 locationNCT07592988
Recruiting
Prospective Observational Multicenter Study of Patients With AH and CKD Markers in Kazakhstan (PROGRESS-CKD)
Rate of CKD Diagnosis in Patients With AH and CKD MarkersDemographic and Clinical Characteristics for Those PatientsRoutine Therapy Before and After the Diagnosis of CKD
AstraZeneca1,282 enrolled29 locationsNCT06744335
Recruiting
Phase 3
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
Primary MyelofibrosisPost-polycythemia Vera MyelofibrosisPost-essential Thrombocythemia Myelofibrosis
Swedish Orphan Biovitrum399 enrolled207 locationsNCT03165734
Recruiting
Phase 1
A Comparative Bioavailability Study of Two Torasemide 10 mg Tablets Formulations in Healthy Adult Participants Under Fasting Conditions:
Healthy Adult Male and Female Volunteers
Berlin-Chemie AG Menarini Group26 enrolled1 locationNCT07201584
Recruiting
Enhancing Management Algorithms for Children Conceived Via Assisted Reproductive Technologies
ARTChildrenAnthropometric Characteristics+3 more
Kazakhstan's Medical University "KSPH"300 enrolled1 locationNCT07278960
Recruiting
iCaReMe Global Registry
Heart FailureHypertensionChronic Kidney Disease+1 more
AstraZeneca35,000 enrolled55 locationsNCT03549754
Recruiting
Not Applicable
Tissue-Engineered Construct Based on Amniotic Membrane and Calcium Alginate for Cesarean Section Wound Healing
Skin Wound Healing After Cesarean SectionCesarean Section Scar Healing
Asfendiyarov Kazakh National Medical University100 enrolled1 locationNCT07241013
Recruiting
Not Applicable
Expanding Medication-Assisted Therapies in Central Asia
Opioid-use Disorder
Yale University900 enrolled4 locationsNCT05579470
Recruiting
Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction
Chronic Kidney DiseasesType 2 DiabetesObesity (Disorder)+2 more
Asfendiyarov Kazakh National Medical University6,720 enrolled1 locationNCT06953180
Recruiting
Clinical Efficacy of Ustekinumab in Crohn's Disease
Crohn's Disease
Kazakhstan Scientific Society for Study of intestine diseases150 enrolled4 locationsNCT06523647
Recruiting
Prospective Urban Rural Epidemiology Study
CancerCardiovascular DiseasesLung Diseases+6 more
Population Health Research Institute200,000 enrolled34 locationsNCT03225586